Why we test what we test

The science behind the panel.

Every marker on the LONVE panel was chosen because it independently predicts healthspan, disease risk, or recovery capacity. Here's what each one tells us.

Pipette dispensing into laboratory test tubes — LONVÉ diagnostic science

Glycemic Control

4 markers
HbA1c
% · ref 4.0–5.6

Three-month average glycemia. Independently predicts cardiovascular and all-cause mortality.

Optimal: 4.65.2
Fasting Glucose
mg/dL · ref 70–99

Screen for impaired fasting glucose; consistent values >100 mg/dL indicate prediabetes.

Optimal: 7288
Fasting Insulin
µIU/mL · ref 2.6–24.9

Earliest detectable marker of insulin resistance — often elevated years before glucose changes.

Optimal: 26
HOMA-IR
index · ref <2.0

Calculated insulin-resistance index (glucose × insulin / 405).

Optimal: 0.51.5

Cardiovascular

6 markers
Apolipoprotein B
mg/dL · ref <100

Counts every atherogenic lipoprotein particle. Superior to LDL-C for cardiovascular risk (AHA 2023).

Optimal: 4080
Lipoprotein(a)
nmol/L · ref <75

Genetic, lifelong cardiovascular risk factor. Should be measured at least once in every adult.

Optimal: 050
LDL-C
mg/dL · ref <100

Conventional atherogenic cholesterol — interpret alongside ApoB.

Optimal: 5090
HDL-C
mg/dL · ref >40 M / >50 F

Reverse cholesterol transport capacity. Very high HDL is not always protective.

Optimal: 5590
Triglycerides
mg/dL · ref <150

Fasting triglycerides correlate with insulin resistance and VLDL load.

Optimal: 4090
TG / HDL ratio
ratio · ref <3.0

Surrogate for insulin sensitivity and small-dense LDL burden.

Optimal: 0.51.5

Inflammation

4 markers
hs-CRP
mg/L · ref <3.0

High-sensitivity C-reactive protein. JUPITER and CANTOS data link it to MACE risk.

Optimal: 01
Homocysteine
µmol/L · ref <11.4

Reflects methylation status; elevated levels associate with vascular and cognitive decline.

Optimal: 57
GGT
U/L · ref 9–48

Sensitive marker of hepatic oxidative stress, often elevated in metabolic syndrome.

Optimal: 1020
Uric Acid
mg/dL · ref 3.4–7.0

Drives endothelial dysfunction at the high end; very low values may reflect malnutrition.

Optimal: 3.55.5

Hormones — Male

3 markers
Total Testosterone
ng/dL · ref 264–916

Endocrine Society 2018 guidelines define hypogonadism <264 ng/dL on two morning draws.

Optimal: 600900
Free Testosterone
pg/mL · ref 9.3–26.5

Bioavailable androgen — the fraction not bound to SHBG or albumin.

Optimal: 1826
Estradiol (M)
pg/mL · ref 10–40

Critical for male bone, brain, and cardiometabolic health. Suppression is harmful.

Optimal: 2035

Hormones — Female

3 markers
Estradiol (F)
pg/mL · ref cycle-dependent

Phase-dependent. Postmenopausal optimization is individualized per NAMS guidelines.

Optimal: 50200
Progesterone
ng/mL · ref cycle-dependent

Mid-luteal progesterone confirms ovulation and supports sleep and mood.

Optimal: 520
FSH
mIU/mL · ref varies

Pituitary signal; >25 mIU/mL with amenorrhea suggests menopausal transition.

Optimal: 310

Hormones — Shared

4 markers
SHBG
nmol/L · ref 10–80

Modulates bioavailable sex hormones. Low SHBG correlates with insulin resistance.

Optimal: 2045
DHEA-S
µg/dL · ref 80–560

Adrenal androgen reserve; declines ~2%/year after age 30.

Optimal: 200400
Cortisol (AM)
µg/dL · ref 6.2–19.4

Drawn between 7–9 AM. Diurnal salivary curves give a fuller picture of HPA-axis function.

Optimal: 1016
IGF-1
ng/mL · ref age-adjusted

Downstream marker of GH axis activity. Optimal range varies by age; very high values associate with cancer risk.

Optimal: 150220

Thyroid

4 markers
TSH
mIU/L · ref 0.4–4.5

Most sensitive screening test. Functional medicine targets 1–2 mIU/L.

Optimal: 0.82
Free T3
pg/mL · ref 2.3–4.2

Active hormone — interpret with reverse T3 for full picture.

Optimal: 3.24
Free T4
ng/dL · ref 0.8–1.8

Storage hormone, converted to T3 peripherally.

Optimal: 1.11.5
TPO Antibodies
IU/mL · ref <35

Positive titer suggests Hashimoto autoimmunity even with normal TSH.

Optimal: 09

Micronutrients

6 markers
Vitamin D (25-OH)
ng/mL · ref 30–100

Endocrine Society defines deficiency <20, insufficiency 20–29 ng/mL.

Optimal: 5080
Vitamin B12
pg/mL · ref 232–1245

Symptoms of deficiency appear well within the lab 'normal' range; pair with MMA.

Optimal: 600900
RBC Folate
ng/mL · ref >280

Better tissue index than serum folate.

Optimal: 400800
Magnesium (RBC)
mg/dL · ref 4.2–6.8

Intracellular magnesium — more sensitive than serum.

Optimal: 66.8
Omega-3 Index
% · ref >4

Erythrocyte EPA+DHA content. <4% associates with sudden cardiac death.

Optimal: 812
Zinc (plasma)
µg/dL · ref 60–120

Required for testosterone synthesis, immune function, wound healing.

Optimal: 90120

Iron Status

2 markers
Ferritin
ng/mL · ref 30–300 M / 13–150 F

Acute-phase reactant — high values can reflect inflammation, not iron overload.

Optimal: 70150
Transferrin Saturation
% · ref 20–50

Screens for hemochromatosis and iron deficiency together with ferritin.

Optimal: 2540